未登录

L

Lre Bereznicki

University of Tasmania

H指数:32

被引数:3,682

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR Trial

IF3.8

2023-04-192

OAAI

Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial (Nov, 10.1007/s40266-022-00983-6, 2022)

IF3.8

2022-12-200

OAAI

Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial

IF3.8

2022-11-237

OAAI

Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review

NPJ PRIMARY CARE RESPIRATORY MEDICINE

IF4.7

2022-11-171

OAAI

Rethinking the gold standard - The feasibility of randomized controlled trials within health services effectiveness research

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-09-012

PRE

Preventing Adverse Drug Reactions After Hospital Discharge (PADR-AD): Protocol for a randomised-controlled trial in older people

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-08-014

OAAI

Actual drug-related harms in residential aged care facilities: a narrative review

EXPERT OPINION ON DRUG SAFETY

IF3.1

2022-06-021

PRE

Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2022-05-013

PRE

Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2022-04-0533

OAAI

Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia

THERAPEUTIC ADVANCES IN DRUG SAFETY

IF3.4

2022-03-117

OAAI

Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2022-02-252

PRE

Reasons for non-adherence to thromboprophylaxis prescribing guidelines in atrial fibrillation in Western Australia: A qualitative descriptive study of general practitioners' views

西澳大利亚州房颤患者不遵守血栓预防处方指南的原因: 全科医生观点的定性描述性研究

THROMBOSIS RESEARCH

IF3.4

2021-12-015

PRE

Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2021-10-1310

OAAI

Strategies for improving guideline adherence of anticoagulants for patients with atrial fibrillation in primary healthcare: A systematic review

改善基层医疗机构心房颤动患者抗凝药物指南依从性策略的系统评价

THROMBOSIS RESEARCH

IF3.4

2021-09-019

PRE

Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic review

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2021-04-2027

OAAI

Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2021-03-019

PREAI

Knowledge, beliefs and management of childhood fever among nurses and other health professionals: A cross-sectional survey

NURSE EDUCATION TODAY

IF4.2

2021-02-015

PREAI

Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: A ten-year follow-up

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2021-01-2214

PREAI

Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IF3.6

2020-12-0314

PREAI

Five-Year Trends in Potential Drug Interactions with Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation: An Australian-Wide Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2020-11-0517

OAAI